Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Key questions on intradialytic parenteral nutrition
British Journal of Renal Medicine, 10/26/09
Protein–energy malnutrition affects 30–70% of haemodialysis patients. It is strongly associated with adverse outcomes. There are numerous reasons why dialysis patients become malnourished. Essentially, there are factors that reduce nutrient intake, and factors that promote catabolism or suppress anabolism.
Related Articles
Formulation, Stability, and Administration of Parenteral Nutrition With New Lipid Emulsions
Nutrition in Clinical Practice, 10/29/09
Relevance Score: 68%
Nutritional risk of hospitalized patients in Turkey
Clinical Nutrition, 10/15/09
Relevance Score: 68%
Clinical Application of Magnetic Resonance Spectroscopy of the Liver in Patients Receiving Long-Term Parenteral Nutrition
Journal of Parenteral and Enteral Nutrition, 11/11/09
Relevance Score: 67%
Neonatal Parenteral Nutrition Hypersensitivity: A Case Report Implicating Bisulfite Sensitivity in a Newborn Infant
Journal of Parenteral and Enteral Nutrition, 11/11/09
Relevance Score: 67%
Initial nutritional management of the preterm infant
Early Human Development, 10/30/09
Relevance Score: 67%
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Plasma Ghrelin Levels Are Associated with Coronary Microvascular and Endothelial Dysfunction in Peritoneal Dialysis Patients
Renal Failure, 11/25/09
Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins
Renal Failure, 11/25/09
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
Nephrology Dialysis Transplantation, 11/24/09
Article Search
Sponsor


See Latest Articles


